April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Macrophage Ablation Suppresses Laser-Induced Choroidal Neovascularization (CNV)
T. Yoshida; J. Shen; C. Seidel; S. Hackett; R. Lang; P. A. Campochiaro
Author Affiliations & Notes
  • T. Yoshida
    Wilmer Eye institute, Johns Hopkins University, Baltimore, Maryland
  • J. Shen
    Wilmer Eye institute, Johns Hopkins University, Baltimore, Maryland
  • C. Seidel
    Wilmer Eye institute, Johns Hopkins University, Baltimore, Maryland
  • S. Hackett
    Wilmer Eye institute, Johns Hopkins University, Baltimore, Maryland
  • R. Lang
    Children’s Hospital Research Foundation, University of Cincinnati, Cincinnati, Ohio
  • P. A. Campochiaro
    Wilmer Eye institute, Johns Hopkins University, Baltimore, Maryland
  • Footnotes
    Commercial Relationships  T. Yoshida, None; J. Shen, None; C. Seidel, None; S. Hackett, None; R. Lang, None; P.A. Campochiaro, None.
  • Footnotes
    Support  NIH Grant EY012609
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1174. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Macrophage Ablation Suppresses Laser-Induced Choroidal Neovascularization (CNV)
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      T. Yoshida, J. Shen, C. Seidel, S. Hackett, R. Lang, P. A. Campochiaro; Macrophage Ablation Suppresses Laser-Induced Choroidal Neovascularization (CNV). Invest. Ophthalmol. Vis. Sci. 2009;50(13):1174.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : The purpose of this study was to explore the role of macrophages in the development of CNV.

Methods: : The size of CNV at sites of Bruch’s membrane rupture with laser was evaluated in transgenic mice in which the CD11b promoter drives expression of diphtheria toxin receptor (DTR) selectively on macrophages with and without injection of diphtheria toxin (DT).

Results: : Intraperitoneal injection of 25 ng/g DT in CD11b-DTR transgenic mice resulted in a marked reduction in F4/80-positive macrophages in the RPE/choroid and retina and a significant reduction in area of CNV at Bruch’s membrane rupture sites. Compared to untreated CD11b-DTR mice (n=51) in which the mean (± SEM) area of CNV was 0.01212±0.00282 mm2, it was significantly less in CD11bDTR mice in which macrophages had been ablated by injection of DT (0.00591±0.0008 mm2, n=39). Real time PCR of total RNA isolated from the RPE/choroid of 5 untreated and 5 DT-treated CD11b-DTR mice, showed that mRNA for macrophage inflammatory protein-1, monocyte chemoattractant protein-1, interleukin-1β, and vascular endothelial growth factor were significantly reduced.

Conclusions: : Severe reduction of macrophages in the retina and choroid suppresses the development of CNV after rupture of Bruch’s membrane.

Keywords: choroid: neovascularization 
© 2009, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2015 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept